Annual Revenue
N/A
30 April 2024
Summary:
KalVista Pharmaceuticals annual revenue is not available.KALV Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
31 July 2024
Summary:
KalVista Pharmaceuticals quarterly revenue is not available.KALV Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
31 July 2024
Summary:
KalVista Pharmaceuticals TTM revenue is not available.KALV TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALV Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
KALV Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
KalVista Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2020 | $12.69 M(-21.3%) | $3.82 M(+142.5%) | $12.69 M(+7.6%) |
| Jan 2020 | - | $1.58 M(-59.8%) | $11.79 M(-16.4%) |
| Oct 2019 | - | $3.92 M(+16.4%) | $14.11 M(-10.6%) |
| July 2019 | - | $3.37 M(+15.1%) | $15.78 M(-2.2%) |
| Apr 2019 | $16.13 M(+92.1%) | $2.93 M(-24.8%) | $16.13 M(-10.6%) |
| Jan 2019 | - | $3.89 M(-30.4%) | $18.04 M(+9.5%) |
| Oct 2018 | - | $5.59 M(+50.4%) | $16.48 M(+37.2%) |
| July 2018 | - | $3.72 M(-23.2%) | $12.02 M(+43.1%) |
| Apr 2018 | $8.39 M(+458.1%) | $4.84 M(+107.6%) | $8.39 M(+128.8%) |
| Jan 2018 | - | $2.33 M(+106.8%) | $3.67 M(+131.4%) |
| Oct 2017 | - | $1.13 M(+1074.0%) | $1.58 M(+240.9%) |
| July 2017 | - | $96.00 K(-15.8%) | $465.00 K(+23.7%) |
| Apr 2017 | $1.50 M | $114.00 K(-54.0%) | $376.00 K(+39.8%) |
| Jan 2017 | - | $248.00 K(+3442.9%) | $269.00 K(+827.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $7000.00(0.0%) | $29.00 K(0.0%) |
| June 2016 | - | $7000.00(0.0%) | $29.00 K(0.0%) |
| Apr 2016 | $2.13 M(+7255.2%) | - | - |
| Mar 2016 | - | $7000.00(-12.5%) | $29.00 K(0.0%) |
| Dec 2015 | $29.00 K(-98.4%) | $8000.00(+14.3%) | $29.00 K(0.0%) |
| Sept 2015 | - | $7000.00(0.0%) | $29.00 K(-9.4%) |
| June 2015 | - | $7000.00(0.0%) | $32.00 K(+6.7%) |
| Apr 2015 | $1.80 M(+6120.7%) | - | - |
| Mar 2015 | - | $7000.00(-12.5%) | $30.00 K(+3.4%) |
| Dec 2014 | $29.00 K(-93.0%) | $8000.00(-20.0%) | $29.00 K(-93.1%) |
| Sept 2014 | - | $10.00 K(+100.0%) | $419.00 K(+2.4%) |
| June 2014 | - | $5000.00(-16.7%) | $409.00 K(+1.2%) |
| Mar 2014 | - | $6000.00(-98.5%) | $404.00 K(+1.5%) |
| Dec 2013 | $415.00 K(-73.0%) | $398.00 K | $398.00 K |
| Dec 2012 | $1.54 M | - | - |
FAQ
- What is the all time high annual revenue for KalVista Pharmaceuticals?
- What is the all time high quarterly revenue for KalVista Pharmaceuticals?
- What is the all time high TTM revenue for KalVista Pharmaceuticals?
What is the all time high annual revenue for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual revenue is $16.13 M
What is the all time high quarterly revenue for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly revenue is $5.59 M
What is the all time high TTM revenue for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high TTM revenue is $18.04 M